The common thread among these types of companies is that they all need substantial capital to develop and rapidly deploy their innovative technology or marketing in a market where timing is often critical..

Very often, they come from the following environments::

Information technology & hardware: software, Internet, eCommerce, telecommunications, engineering sciences, components, microchips, nano tech...

Biotechnologies & life sciences: therapeutic molecules & drugs development, medical devices, software solutions dedicated to the health sector...

Other sectors : marketing innovation, distribution and/or logistic differentiation, corporate and mass market services, ...

These companies often have experienced first success and profitability in their historical business sector, but now wish to accelerate their growth or develop other market segments. Whatever the sector, developing SMEs in full acceleration often require capital injections to sustain their growth.

Such development strategy can be of two kinds (or a combination of both):

Organic growth: Capital injection by specialized investors to sustain their development, add value to the existing management by bringing on board seasoned investors and eventually promote external growth.

External growth: There are various external growth strategies. Bringing together related businesses with the purpose of either horizontal or vertical integration, or finding critical corporate mass through approaching competitors.

The common ground among these take-over companies is the strong legitimacy of the teams in the company taken over by leverage transactions ( MBO if it involves corporate management or MBI if it involves management coming from outside the targets)..

This type of transaction requires support on two fronts:

Targeted company's shareholders & management: Assistance in approaching and in negotiating with existing shareholders and management

Transaction financing: building the buyout structure, debt and capital analysis, with banks and specialized funding sources.

These companies share the following common points: in anticipation of, or after an endogenous or exogenous factor (take over, LBO, legal issues…) it is necessary to restructure either their activity and/or their capital

This type of operation is undertaken, in various ways, each individually adapted to a situation. Aelios Finance becomes involved with companies whose core activity itself in undergoing transformation: concentration on core activities, divestiture of ancillary businesses requiring a series of merger and acquisitions operations.